Cuscuta chinensis extract promotes osteoblast differentiation and mineralization in human osteoblast-like MG-63 cells

Journal of Medicinal Food

Volumn 12, Issue 1, 2009, Pages 85-92

  Yang, Hyun Mo ^a   Shin, Hyun Kyung ^a   Kang, Young Hee ^a   Kim, Jin Kyung ^a  

^a Hallym University   (South Korea)

Author keywords

Alkaline phosphatase; Mineralization; Osteoblast differentiation; Osteocalcin

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; CUSCUTA CHINENSIS EXTRACT; OSTEOCALCIN;

ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL LINE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OSTEOBLAST; PLANT SEED; PRIORITY JOURNAL;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; COLLAGEN; CUSCUTA; HUMANS; OSTEOBLASTS; OSTEOCALCIN; OSTEOPOROSIS; PHYTOTHERAPY; PLANT EXTRACTS; RNA, MESSENGER; SEEDS;

CUSCUTA CHINENSIS;

EID: 64949104330     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.0665     Document Type: Article

References (40)

1. Leboy PS: Regulating bone growth and development with bone morphogenetic proteins. Ann N Y Acad Sci 2002;1068:14-18.
2. Janssens K, ten Dijke P, Janssens S, Van Hul W: Transforming growth factor-beta1 to the bone. Endocr Rev 2005;26;743-774.
3. Aubin JE: Bone stem cells. J Cell Biochem Suppl 1998;30-31: 73-82.
4. Quarles LD, Yohay DA, Lever LW, Caton R, Wenstrup RJ: Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res 1992;7:683-692.
5. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS: Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990;143;420-430.
6. Urist MR: Bone: formation by autoinduction. Science 1965;150: 893-899.
7. Maegawa N, Kawamura K, Hirose M, Yajima H, Takakura Y, Ohgushi H: Enhancement of osteoblastic differentiation of mes-enchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med 2007;1:306-313.
8. ten Dijke P: Bone morphogenetic protein signal transduction in bone. Curr Med Res Opin 2006;22(Suppl 1):S7-S11.
9. Otsuka E, Notoya M, Hagiwara H: Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts. Calcif Tissue Int 2003;73:72-77.
10. Nakamura M, Udagawa N, Yamamoto Y, Nakamura H: BMP and osteoclastogenesis. Clin Calcium 2006;16:809-815.
11. Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa-Sehara A, Suda T: Bone mor-phogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994;127:1755-1766.
12. Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C: Immunoassay for quantifying type I collagen degradation products in urine. Clin Chem 1994;40:2022-2025.
13. Andrianarivo G, Robinson JA, Mann JG, Tracy RP: Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J Cell Physiol 1992;153: 256-265.
14. Takeuchi Y, Suzawa M, Kikuchi T, Nishida E, Fujita T, Matsumoto T: Differentiation and transforming growth factor-beta receptor down-regulation by collagen-alpha2beta1 integrin interaction is mediated by focal adhesion kinase and its downstream signals in murine osteoblastic cells. J Biol Chem 1997;272: 29309-29316.
15. Xiao G, Wang D, Benson MD, Karsenty G, Franceschi RT: Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem 1998;273:32988-32994.
16. Mizuno M, Kuboki Y: Osteoblast-related gene expression of bone marrow cells during the osteoblastic differentiation induced by type I collagen. J Biochem (Tokyo) 2001;129:133-138.
17. Arjmandi BH: The role of phytoestrogens in the prevention and treatment of osteoporosis in ovarian hormone deficiency. J Am Coll Nutr 2001;20(Suppl):398S-402S.
18. Clarke MS: The effects of exercise on skeletal muscle in the aged. J Musculoskel Neuronal Interact 2004;4:175-178.
19. Frost HM: Coming changes in accepted wisdom about "osteoporosis. " J Musculoskel Neuronal Interact 2004;4:78-85.
20. Christiansen C, Lindsay R: Estrogens, bone loss and preservation. Osteoporos Int 1990;1:7-13.
21. Nordstrom AC, Nyquist KF, Olsson T, Nordstrom P, Karlsson M: Bone loss and fracture risk after reduced physical activity. J Bone Miner Res 2005;20:202-207.
22. Chen KM, Ge BF, Ma HP, Liu XY, Bai MH, Wang Y: Icariin, a flavonoid from the herb Epimedium enhances the osteogenic dif- ferentiation of rat primary bone marrow stromal cells. Pharmazie 2005;60:939-942.
23. Du XM, Kohinata K, Kawasaki T, Guo YT, Miyahara K: Components of the ether-insoluble resin glycoside-like fraction from Cuscuta chinensis. Phytochemistry 1998;48:843-850.
24. Yen FL, Wu TH, Lin LT, Lin CC: Hepatoprotective and antioxidant effects of Cuscuta chinensis against acetaminopheninduced hepatotoxicity in rats. J Ethnopharmacol 2007;111 :123-128.
25. Nisa M, Akbar S, Tariq M, Hussain Z: Effect of Cuscuta chinensis water extract on 7,12-dimethylbenz[a]anthracene-induced skin papillomas and carcinomas in mice. J Ethnopharmacol 1986;18:21-31.
26. Hsieh TC, Lu X, Guo J, Xiong W, Kunicki J, Darzynkiewicz Z, Wu JM: Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies. Int J Oncol 2002;20:681-689.
27. Chung TW, Koo BS, Choi EG, Kim MG, Lee IS, Kim CH: Neuroprotective effect of a chuk-me-sun-dan on neurons from ischemic damage and neuronal cell toxicity. Neurochem Res 2006;31:1-9.
28. Liu JH, Jiang B, Bao YM, An LJ: Effect of Cuscuta chinensis glycoside on the neuronal differentiation of rat pheochromocy-toma PC12 cells. Int J Dev Neurosci 2003;21:277-281.
29. Yao CH, Tsai HM, Chen YS, Liu BS: Fabrication and evaluation of a new composite composed of tricalcium phosphate, gelatin, and Chinese medicine as a bone substitute. J Biomed Mater Res B Appl Biomater 2005;75:277-288.
30. Drissi H, Hott M, Marie PJ, Lasmoles F: Expression of the CT/CGRP gene and its regulation by dibutyryl cyclic adenosine monophosphate in human osteoblastic cells. J Bone Miner Res 1997;12:1805-1814.
31. Ferrari N, Pfeffer U, Dell'Eva R, Ambrosini C, Noonan DM, Albini A: The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydrox-yphenyl)retinamide. Clin Cancer Res 2005;11:4610-4619.
32. Li J, Zhao Z, Wang J, Chen G, Yang J, Luo S: The role of extracellular matrix, integrins, and cytoskeleton in mechanotrans-duction of centrifugal loading. Mol Cell Biochem 2008; 309:41-48.
33. Lajeunesse D, Frondoza C, Schoffield B, Sacktor B: Osteocalcin secretion by the human osteosarcoma cell line MG-63. J Bone Miner Res 1990;5:915-922.
34. Clover J, Gowen M: Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? Bone 1994;15:585-591.
35. Ruiz-Gaspa S, Nogues X, Enjuanes A, Monllau JC, Blanch J, Carreras R, Mellibovsky L, Grinberg D, Balcells S, Diez-Perez A, Pedro-Botet J: Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human os-teoblasts and MG-63 cultures. J Cell Biochem 2007;101:1430-1438.
36. Chang JK, Hsu YL, Teng IC, Kuo PL: Piceatannol stimulates os-teoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production. Eur J Pharmacol 2006;551: 1-9.
37. Bao X, Wang Z, Fang J, Li X: Structural features of an im-munostimulating and antioxidant acidic polysaccharide from the seeds of Cuscuta chinensis. Planta Med 2002;68:237-243.
38. Umehara K, Nemoto K, Ohkubo T, Miyase T, Degawa M, Noguchi H: Isolation of a new 15-membered macrocyclic glycolipid lactone, cuscutic resinoside a from the seeds of Cuscuta chinensis: a stimulator of breast cancer cell proliferation. Planta Med 2004;70:299-304.
39. Wang Z, Fang JN, Ge DL, Li XY: Chemical characterization and immunological activities of an acidic polysaccharide isolated from ET AL. the seeds of Cuscuta chinensis Lam. Acta Pharmacol Sin 2000;21:1136-1140.
40. Ye M, Yan Y, Guo DA: Characterization of phenolic compounds in the Chinese herbal drug Tu-Si-Zi by liquid chromatography coupled to electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom 2005;19:1469-1484.